Shashanka Muppaneni currently serves as the Group Vice President of Strategy & Business Development for the Diagnostics Platform at Danaher Corporation, overseeing a diverse portfolio that includes Beckman Coulter, Cepheid, and others. Previously, Shashanka was a Managing Director & Partner at Boston Consulting Group, where leadership roles encompassed global healthcare and corporate finance, as well as heading the Life Sciences Tools & Diagnostics practice. Additional experience includes leading corporate development and strategy at Seer, guiding corporate strategy at Illumina, and various strategy and development roles at Upsher-Smith Laboratories, Smiths Group, Cummins, and Microsoft. Shashanka's educational background includes a degree from the University of Minnesota's Carlson School of Management.